Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-12-28

Clinical Trial Update: Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain Tumor [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluated a vaccine therapy in combination with sargramostim for patients with sarcoma or brain/central nervous system tumors; the study has bee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • sargramostim (sargramostim)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Brain and Central Nervous System Tumors, Gastrointestinal Stromal Tumor | Phase 1 | Status: COMPLETED